This inventor holds 7 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Mitochon Pharmaceuticals, Inc., Bioventures, LLC. Active years: 2017-2023.
Company Filing History:
7 out of 7 
2 out of 99 
Years Active: 2017-2023
Title: John Gerard Geisler: Innovator in Neuromuscular and Neurodegenerative Treatments
Introduction
John Gerard Geisler is a prominent inventor based in Blue Bell, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of neuromuscular and neurodegenerative diseases. With a total of 7 patents to his name, Geisler's work focuses on innovative methods to address complex health issues.
Latest Patents
Geisler's latest patents include groundbreaking methods for inducing the expression of brain-derived neurotrophic factor (BDNF) to treat various diseases. His research outlines a method for treating conditions such as traumatic injury, stroke, Huntington's disease, and multiple sclerosis, among others. By administering DNP to mice, he demonstrated a dose-dependent increase in BDNF expression, which is crucial for protecting against neuromuscular dysfunction and neurodegeneration. Another patent details a composition and method for treating a range of diseases, including spinal muscular atrophy and traumatic brain injury, using specific dinitrophenol compounds.
Career Highlights
Throughout his career, Geisler has worked with notable companies such as Mitochon Pharmaceuticals, Inc. and Bioventures, LLC. His innovative approaches have positioned him as a key figure in the development of treatments for debilitating conditions. His extensive research and patent portfolio reflect his commitment to advancing medical science.
Collaborations
Geisler has collaborated with esteemed colleagues, including Robert Alonso and Peter Anthony Crooks. These partnerships have further enriched his research and contributed to the success of his innovative projects.
Conclusion
John Gerard Geisler's contributions to the field of neuromuscular and neurodegenerative treatments highlight his role as a leading inventor. His patents and collaborative efforts continue to pave the way for advancements in medical therapies.